219 related articles for article (PubMed ID: 20696662)
21. A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression.
Xu B; Wang J; Tong N; Mi Y; Min Z; Tao J; Li P; Cheng G; Li J; Wang M; Tang J; Song N; Zhang Z; Zhang W; Wu H; Hua L; Feng N
Prostate; 2010 Jul; 70(10):1146-52. PubMed ID: 20333697
[TBL] [Abstract][Full Text] [Related]
22. A meta-analysis of influence of MSMB promoter rs10993994 polymorphisms on prostate cancer risk.
Fu S; Huang YL; Luan T; Li N; Wang HF; Wang JS
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9295-9303. PubMed ID: 31773691
[TBL] [Abstract][Full Text] [Related]
23. Personalized prostate cancer screening: improving PSA tests with genomic information.
Witte JS
Sci Transl Med; 2010 Dec; 2(62):62ps55. PubMed ID: 21160075
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide association study identifies genetic determinants of urine PCA3 levels in men.
Chen Z; Sun J; Kim ST; Groskopf J; Feng J; Isaacs WB; Rittmaster RS; Condreay LD; Zheng SL; Xu J
Neoplasia; 2013 Apr; 15(4):448-53. PubMed ID: 23555189
[TBL] [Abstract][Full Text] [Related]
25. The prostate cancer risk locus at 10q11 is associated with DNA repair capacity.
Rinckleb AE; Surowy HM; Luedeke M; Varga D; Schrader M; Hoegel J; Vogel W; Maier C
DNA Repair (Amst); 2012 Aug; 11(8):693-701. PubMed ID: 22677538
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels.
Li W; Bicak M; Sjoberg DD; Vertosick E; Dahlin A; Melander O; Ulmert D; Lilja H; Klein RJ
Prostate; 2020 Dec; 80(16):1405-1412. PubMed ID: 32914890
[TBL] [Abstract][Full Text] [Related]
27. Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression.
FitzGerald LM; Zhang X; Kolb S; Kwon EM; Liew YC; Hurtado-Coll A; Knudsen BS; Ostrander EA; Stanford JL
Hum Mutat; 2013 Jan; 34(1):149-56. PubMed ID: 22887727
[TBL] [Abstract][Full Text] [Related]
28. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity.
Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG
Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595
[TBL] [Abstract][Full Text] [Related]
29. MSMB gene variant alters the association between prostate cancer and number of sexual partners.
Stott-Miller M; Wright JL; Stanford JL
Prostate; 2013 Dec; 73(16):1803-9. PubMed ID: 24037734
[TBL] [Abstract][Full Text] [Related]
30. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.
Cramer SD; Chang BL; Rao A; Hawkins GA; Zheng SL; Wade WN; Cooke RT; Thomas LN; Bleecker ER; Catalona WJ; Sterling DA; Meyers DA; Ohar J; Xu J
J Natl Cancer Inst; 2003 Jul; 95(14):1044-53. PubMed ID: 12865450
[TBL] [Abstract][Full Text] [Related]
31. Mutation analysis of the MSMB gene in familial prostate cancer.
Kote-Jarai Z; Leongamornlert D; Tymrakiewicz M; Field H; Guy M; Al Olama AA; Morrison J; O'Brien L; Wilkinson R; Hall A; Sawyer E; Muir K; Hamdy F; Donovan J; Neal D; Easton D; Eeles R
Br J Cancer; 2010 Jan; 102(2):414-8. PubMed ID: 19997100
[TBL] [Abstract][Full Text] [Related]
32. Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections.
Siivola P; Pettersson K; Piironen T; Lövgren T; Lilja H; Bjartell A
Urology; 2000 Oct; 56(4):682-8. PubMed ID: 11018639
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
Klein RJ; Hallden C; Gupta A; Savage CJ; Dahlin A; Bjartell A; Manjer J; Scardino PT; Ulmert D; Wallström P; Vickers AJ; Lilja H
Eur Urol; 2012 Mar; 61(3):471-7. PubMed ID: 22101116
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer risk SNP rs10993994 is a trans-eQTL for SNHG11 mediated through MSMB.
Bicak M; Wang X; Gao X; Xu X; Väänänen RM; Taimen P; Lilja H; Pettersson K; Klein RJ
Hum Mol Genet; 2020 Jun; 29(10):1581-1591. PubMed ID: 32065238
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.
Abrahamsson PA; Lilja H; Falkmer S; Wadström LB
Prostate; 1988; 12(1):39-46. PubMed ID: 2450341
[TBL] [Abstract][Full Text] [Related]
36. [PSA and hK2 in the diagnosis of prostate cancer].
Alapont Alacreu JM; Navarro Rosales S; Budía Alba A; España Furió F; Morera Martínez F; Jiménez Cruz JF
Actas Urol Esp; 2008 Jun; 32(6):575-88. PubMed ID: 18655340
[TBL] [Abstract][Full Text] [Related]
37. Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
Wiklund F; Zheng SL; Sun J; Adami HO; Lilja H; Hsu FC; Stattin P; Adolfsson J; Cramer SD; Duggan D; Carpten JD; Chang BL; Isaacs WB; Grönberg H; Xu J
Prostate; 2009 Mar; 69(4):419-27. PubMed ID: 19116992
[TBL] [Abstract][Full Text] [Related]
38. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA.
Magklara A; Scorilas A; Catalona WJ; Diamandis EP
Clin Chem; 1999 Nov; 45(11):1960-6. PubMed ID: 10545066
[TBL] [Abstract][Full Text] [Related]
39. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Huber A; Lümmen G; Tscholl R
Urology; 2000 Apr; 55(4):481-5. PubMed ID: 10736487
[TBL] [Abstract][Full Text] [Related]
40. Ejaculates from the common marmoset (Callithrix jacchus) contain semenogelin and beta-microseminoprotein but not prostate-specific antigen.
Valtonen-André C; Olsson AY; Nayudu PL; Lundwall A
Mol Reprod Dev; 2005 Jun; 71(2):247-55. PubMed ID: 15791587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
